International audiencePurpose: To report the effect of intravitreal anti VEGF injections (IVI) on visual acuity (VA) in eyes with choroidal neovascularisation (CNVM) and coexistent vitreomacular traction (VMT) or when VMT has developed during the course of treatment. Methods: Retrospective interventional case series of 7 eyes in 7 patients. VMT was monitored with serial optical coherence tomography scans. Results: The aetiology of the CNVM was wet age-related macular degeneration in 5 eyes (72%), angioid streaks in 1 eye (14%) and pathological myopia in 1 eye (14%). Ranibizumab was used in 4 eyes (57%) and bevacizumab in 3 (43%) for the active CNVM component. The mean follow-up was 11 months (range 2-28 months). Visual acuity was stabilized or improved in 5 of the 7 eyes (71%) with IVI. Visual acuity results across the whole group were gain of 3 or more lines of Snellen visual acuity in 2 eyes (28%), gain of up to 3 lines in 3 eyes (42%), no change in visual acuity in 1 eye (14%) and loss of up to 3 lines in 1 eye (14%). In 4 eyes with pre-existing VMT, VA improved in 3 with IVI. In 3 eyes that developed VMT after IVI, VA improved in 2 with IVI. Delay from diagnosis of CNVM to treatment with IVI contributed to a poor response. Conclusions: Most eyes improved VA with IVI for combined CNVM and VMT. Despite the often dramatic features of VMT on optical coherence tomography, treatment of co-existing CNVM should be prompt
